Redness, dimpling, and orange peel-like skin on the breast — signs of inflammatory breast cancer. Don't wait.
- ป้าหมอนุช
- 4 hours ago
- 10 min read
⚠️ Very Important: If your breasts become red, swollen, warm, develop an orange peel (skin discoloration), dimpling, or thickening rapidly within a week to a month — especially if you are not breastfeeding — it could be a sign of Inflammatory Breast Cancer (IBC), a very rapidly spreading type of breast cancer. You must see a breast specialist within 24-48 hours. Do not wait! IBC is often misdiagnosed as mastitis — if your condition doesn't improve with antibiotics within 1-2 weeks, suspect IBC and perform a skin biopsy immediately.
Why are changes in the breast skin important?
The skin of the breast is the best mirror reflecting the condition of the inner tissues — changes in the breast skin can indicate a variety of diseases, from common infections to one of the most rapidly spreading forms of breast cancer: Inflammatory Breast Cancer (IBC).
Important information:
Inflammatory Breast Cancer (IBC) — accounts for only 1-5% of all breast cancers, but it is the most rapidly spreading and aggressive type.
The 5-year survival rate for IBC is only 40% (compared to 90%+ for general breast cancer).
Delayed diagnosis is a major problem because IBC is often mistaken for mastitis.
Orange peel texture (Peau d'orange) — a classic IBC hallmark that shouldn't be overlooked.
Every hour counts — rushing to see a specialist can save a life.
Inflammatory Breast Cancer (IBC)
IBC is a form of breast cancer where cancer cells invade and block the lymphatic vessels in the breast skin, causing inflammation and redness that resembles an infection — but it's not an infection.
Symptoms of IBC develop rapidly, within 1-2 weeks to 3 months.
Breast redness/inflammation — more than 1/3 of the breast.
One breast swells, enlarges rapidly — often noticeably larger than the other.
Her breasts were hot — you could feel them.
Orange peel texture (Peau d'orange) — the most important characteristic.
Skin thickening
Breast pain — sometimes severe, like a burning sensation.
Nipple inversion has just occurred.
Enlarged lymph nodes in the armpit — usually enlarged and palpable.
No palpable lump — Unlike typical breast cancer, IBCs usually do not have a palpable mass.
Why are IBCs so dangerous?
It spreads very quickly — within weeks to months.
Most are in Stage III or IV when diagnosed.
A mammogram may not show any visible lumps because there are no clearly defined masses.
It is often misdiagnosed as mastitis in breastfeeding women or cellulitis in general women.
IBC cancer cells are often HER2-positive or triple-negative and spread rapidly.
Mastitis vs. IBC — How to Differentiate Them Correctly
Differentiating mastitis from inflammatory breast cancer (IBC) is crucial because the initial symptoms are very similar, but the treatments are completely different. Mastitis is treated with antibiotics, while IBC requires chemotherapy, surgery, and radiation therapy.
Mastitis (inflammation of the breast due to infection)
It is more common in breastfeeding women (lactational mastitis) or women who smoke.
Start with a small area and gradually expand.
High fever (> 38.5°C)
It hurts so much. I can't even touch it.
Improvement is expected within 48-72 hours after starting antibiotics.
High white blood cell count.
Responds well to warm compresses, massage, and breastfeeding.
IBC (Inflammatory Breast Cancer)
Not breastfeeding (mostly).
Occurs in most or all (>1/3) breasts.
Usually no fever or low-grade fever.
Mild to moderate pain — sometimes like a burn.
⚠️ No improvement within 1-2 weeks after taking antibiotics.
The orange peel texture is clearly visible.
The axillary lymph nodes are enlarged and hard.
The skin appears noticeably thicker.
Important rule:
If a woman is receiving antibiotics for mastitis but her symptoms do not improve within 1-2 weeks , or if symptoms recur , a skin biopsy (punch biopsy) must be performed immediately to differentiate IBC from mastitis. Do not administer a second round of antibiotics without a biopsy.
Other changes in breast skin that should be watched out for.
1. Skin Dimpling
A dimpling in the breast skin is caused by Cooper's ligaments being pulled inward by a cancerous tumor or fibrous tissue — most noticeable when raising your arms or tensing your chest muscles.
cause:
Breast cancer — the most serious cause to watch out for.
Fat necrosis — after injury or surgery.
Post-surgical scarring — After breast surgery
Mondor's Disease — Superficial thrombophlebitis of the breast surface.
2. Skin Thickening
The skin of the breast is thicker than normal, clearly visible or palpable — often found in IBC, Locally Advanced Breast Cancer, or radiation-induced changes.
3. Orange peel (Peau d'Orange)
The skin of the breast has an orange peel-like appearance, characterized by numerous small pores, caused by blockages of lymphatic vessels in the breast surface from IBC — a classic sign of IBC.
How to check:
Stand in front of a mirror in a well-lit area.
View the breast skin from different angles.
Compare it to the other breast.
Take photos to track changes.
4. Redness of the breast skin (Erythema)
Abnormal breast redness — causes need to be differentiated:
Mastitis — Localized redness, fever, improves within 48-72 hours after antibiotic treatment.
Cellulitis — Bacterial skin infection · Fever · Improves with antibiotics.
Inflammatory Breast Cancer (IBC) — Redness on half or the entire breast; does not improve with antibiotics.
Radiation Dermatitis — Post-radiation cancer treatment
Allergic reaction — to shampoo, lotion, perfume.
5. Skin Retraction
A crease in the skin of the breast—become visible when the chest muscles are tensed or the arms are raised—may indicate breast cancer that has spread to the skin.
6. Ulceration (wound on the breast surface)
Advanced breast cancer may cause a lesion on the breast skin — often non-healing, easily bleeding, and foul-smelling — requiring urgent treatment.
Paget's Disease of the Nipple — A disease requiring special attention.
Paget's disease is a rare form of breast cancer (1-3% of all breast cancers) in which cancer cells from DCIS, or invasive breast cancer, migrate to the nipple surface.
Symptoms to watch out for:
Rash/sores on the nipple or areola.
Itchy nipples
Peeling skin on the nipples
Bleeding/fluid discharge from the nipple.
Sore and burning sensation in the nipples.
Flat or indented nipples
Differentiate from eczema (skin disease):
Eczema: Usually affects both sides; occurs in the areola before the nipple; improves with steroid cream; recurs intermittently.
Paget's: Usually unilateral; starts in the nipple first; doesn't improve with steroids; doesn't go away.
⚠️ A rash on the nipple that does not resolve within 2 weeks requires a skin biopsy to rule out Paget's Disease.
Decision Tree — What to do if breast skin changes?
🚨 Go to the ER within 24 hours if:
Breast redness, swelling, and warmth, occurring rapidly, and not breastfeeding.
The orange peel (Peau d'orange) is clearly visible.
Breasts can grow rapidly within days to weeks.
High fever (> 39°C) + severe pain
🟠 See a breast specialist within 48 hours if:
Breast redness develops gradually (1-2 weeks).
Dimpled/Retracted Breast Skin
Nipple retracted inward, recently born.
A rash/sore on the nipple that does not heal within 2 weeks.
Lymph/blood coming out of the nipple.
The skin on the breasts becomes abnormally thickened.
🟡 See a doctor within 1-2 weeks if:
Mastitis was treated with antibiotics but did not improve within 1 week.
Breast lumps accompanied by skin changes.
The skin on the breasts undergoes progressive changes.
🟢 Monitor and observe symptoms if:
Slight redness on the breast skin may be due to an allergic reaction to the lotion/shampoo (try discontinuing use).
Stable post-surgical indentation.
Stretch marks from weight changes.
Diagnosis — Skin Biopsy + Imaging
Diagnosing IBC and breast surface disease requires a specific process, different from typical breast cancer.
1. Skin Punch Biopsy
The gold standard for diagnosing IBC is a 4-6 mm breast biopsy using local anesthesia, revealing dermal lymphatic invasion of cancer cells.
2. Mammogram + Ultrasound
⚠️ A mammogram may appear normal in the IBC (Intracytoplasmic Sclerosis) because there are no obvious masses — but it's still necessary to look for any hidden masses. Ultrasound helps assess skin thickening and axillary nodes.
3. Breast MRI
MRI is highly sensitive in detecting IBC and assessing the extent of the disease. It is used in high-risk patients and for pre-treatment planning.
4. Core Needle Biopsy
If a mass or imaging findings are present, a core needle biopsy should be performed to identify invasive components and molecular markers (ER, PR, HER2, Ki-67).
5. Staging Studies
Once the IBC is confirmed, complete the staging process:
CT Chest/Abdomen/Pelvis
Bone Scan
PET-CT (in some cases)
Sentinel Lymph Node Biopsy or Axillary Lymph Node Dissection
IBC Treatment — Trimodality Therapy
IBC requires a more intensive multimodal treatment approach than typical breast cancer — using all three modalities in sequence.
1. Neoadjuvant Chemotherapy (pre-surgery)
Anthracycline + Taxane regimen (e.g., AC-T)
Add Trastuzumab + Pertuzumab if HER2-positive.
Add Pembrolizumab if Triple-Negative (KEYNOTE-522).
It takes 4-6 months.
Evaluate the response after completion.
2. Modified Radical Mastectomy
Total mastectomy + Axillary Lymph Node Dissection · ⚠️ Lumpectomy is not recommended in IBC due to the high rate of local recurrence. · Immediate reconstruction is generally not recommended as it may delay radiation therapy.
3. Post-Mastectomy Radiation Therapy (PMRT)
Radiation therapy to the chest wall and regional lymph nodes. Duration: 5-6 weeks. Reduces local recurrence by 50% or more.
4. Adjuvant Therapy
Endocrine therapy if HR-positive (Tamoxifen or AI).
Trastuzumab + Pertuzumab maintenance if HER2-positive (1 year)
If residual disease persists after neoadjuvant therapy (KATHERINE).
Capecitabine if TNBC still has residual disease (CREATE-X)
Pembrolizumab maintenance if TNBC (KEYNOTE-522)
Prognosis and disease forecasting.
The prognosis of IBC depends on several factors — early diagnosis and appropriate treatment greatly improve the chances of survival.
5-Year Survival Rate: 40-50% (compared to 90%+ for general breast cancer)
Stage III IBC: 5-year survival 40-50%
Stage IV IBC (Metastatic): 5-year survival 11-20%
Pathologic Complete Response (pCR) after neoadjuvant therapy — is the best predictor factor; survival rate improves significantly.
HER2-positive IBC — Prognosis improved significantly with targeted therapy (Trastuzumab + Pertuzumab).
Triple-Negative IBC — Has the worst prognosis, but immunotherapy (Pembrolizumab) can improve the results.
IBC treatment at Numarak Hospital.
As a specialized breast disease hospital, we have a system in place for emergency cases, such as IBC (Intensive Care Unit).
Rapid Access Protocol for IBC
24-Hour Emergency Appointment — For suspected IBC cases, the PJC team will contact you within 2 hours.
Skin Punch Biopsy on the first day — Performed in the examination room using local anesthesia.
Comprehensive imaging services available 24 hours a day — Mammogram + Ultrasound + MRI
Pathology results in 2-3 days — Express turnaround for urgent cases.
Multidisciplinary Tumor Board — Review case and plan treatment within 1 week.
Neoadjuvant chemotherapy can be started within 2 weeks — reducing treatment delay.
The High Tech, High Touch philosophy for emergency situations.
At Namarak Hospital, we understand that receiving emergency breast cancer diagnosis, such as IBC (Initial Breast Cancer Diagnosis), is one of the most difficult times . "Like visiting a friend's house" means we'll be there for the patient every step of the way — our Patient Journey Coordinator team will provide care, consultation, and help simplify treatment so that patients and their families can get through this period together.
Frequently Asked Questions (FAQ)
Is breast redness every time a sign of IBC?
No — the most common cause of breast redness is mastitis (infectious mastitis), which is a harmless condition treatable with antibiotics. IBC (Infectious Bleeding Chloritis) is a rare but dangerous cause — the key difference is that mastitis improves within 48-72 hours after antibiotics, but IBC does not. Therefore, if breast redness does not improve within 1-2 weeks after antibiotic treatment, suspect IBC and perform a skin biopsy immediately.
Can IBC (Intracytoplasmic Sclerosis) be detected on a mammogram?
Mammograms have low sensitivity for IBCs because IBCs often do not present with clearly defined masses. A mammogram may only show skin thickening or nonspecific diffuse density. Therefore, diagnosing IBCs requires a combination of clinical examination, skin punch biopsy, and MRI, not a mammogram alone.
Why do IBCs rarely have lumps?
Because IBCs spread through the lymphatic vessels in the skin of the breast, not as a lump—the cancer cells spread as a patch in the skin and breast tissue, causing swelling, redness, and inflammation throughout the breast, similar to an infection. The absence of a lump makes IBCs difficult to diagnose and often leads to delayed diagnosis.
At what age is IBC (Intracytoplasmic Sclerosis) most common?
IBCs are found in younger women than typical breast cancer — with an average age of 52 years. They are more common in Black women than White women. They are also more common in obese women (BMI > 30). IBCs in women under 40 are relatively common, while typical breast cancer in women under 40 is rare.
Can orange peel skin disappear on its own?
No — the orange peel skin caused by IBC will not go away on its own and will worsen if left untreated. Any slight improvement in the orange peel skin after antibiotics may be due to a secondary infection of the skin damaged by the IBC, but the cancer itself is still present and spreading.
Is redness on the breasts during breastfeeding something to worry about?
Most cases are lactational mastitis, which can be treated with antibiotics. However, IBC (Intracytoplasmic Spondylitis) can also occur in breastfeeding women (Pregnancy-Associated Breast Cancer). Therefore, if mastitis does not improve within 1-2 weeks, or if symptoms worsen, a skin biopsy should be performed to rule out IBC without waiting for breastfeeding to stop.
Can IBC be cured?
IBC (Invasive Breast Cancer) is treatable, even though the prognosis is worse than for typical breast cancer — a 5-year survival rate of 40-50% for Stage III. Correct and complete treatment (neoadjuvant chemotherapy + mastectomy + radiation + adjuvant therapy) can lead to a cure for a number of patients. The key factors are early diagnosis and multimodal treatment by a team of specialists.
Should I be worried about breast dimpling from a previous surgery?
If the dimpling remains constant and in the same location long after surgery, there's no need to worry. However, if the dimpling changes size, location, or new dimpling occurs, a reassessment is necessary. Regular follow-up examinations are recommended after breast surgery, especially in women who have previously had breast cancer.
See a breast specialist urgently.
If you experience breast redness, dimpling, orange peel-like texture, or any other unusual skin changes, do not wait — contact Numarak Hospital immediately .
24-hour hotline: 02-059-0245
LINE: @namarak (page.line.me/vfg3683z)
Read more
About the editor.
Assoc. Prof. Yaowanuch Kongdan , M.D., Breast Surgeon + Surgical Oncologist · Founder and Director of Namarak Hospital · President of the Thai Breast Disease Society (TBS)
Note: This article is for general information only and cannot replace diagnosis and advice from a specialist. Suspicious changes in breast skin, especially those that develop rapidly, must be evaluated by a breast specialist without delay, as inflammatory breast cancer spreads rapidly and every hour is critical.
References
NCCN Clinical Practice Guidelines—Breast Cancer (Version 2.2025)
Dawood S et al. International Expert Panel on Inflammatory Breast Cancer. Annals of Oncology 2011
Robertson FM et al. Inflammatory Breast Cancer: The Disease, The Biology, The Treatment. CA Cancer J Clin 2010
ACR BI-RADS Atlas 5th Edition — American College of Radiology
KEYNOTE-522 Trial — Pembrolizumab + Chemo for Early TNBC including IBC
Yamauchi H et al. Inflammatory Breast Cancer: What We Know and What We Need to Learn. The Oncologist 2012
Comments